Task: Answer the multiple choice question.
Question: Which drug exhibits a 15.461\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COc1ccc(C/C(C)=N\NC(=O)c2cn(C)c3ccccc23)cc1OC
b N#Cc1nc(COc2ccccc2F)oc1N1CCCCCC1
c CCN(CC)C(=O)CC(c1ccc(N(C)C)cc1)c1c(O)cc(OC)cc1OC
Answer: a. COc1ccc(C/C(C)=N\NC(=O)c2cn(C)c3ccccc23)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C/C(C)=N\NC(=O)c2cn(C)c3ccccc23)cc1OC
COc1ccc(C/C(C)=N\NC(=O)c2cn(C)c3ccccc23)cc1OC
N-[(Z)-1-(3,4-dimethoxyphenyl)propan-2-ylideneamino]-1-methylindole-3-carboxamide